* Reduced proliferation, migration, and invasion of nasopharyngeal carcinoma cells via STAT3, p-STAT3, CCND2, and MMP-2 (17).* CDK4 and CDK6 are miR-124 targets (18).* Impact HER2 signaling in breast cancer patients (52). This evidence concerns the gene CDK6 and breast carcinoma.